Treatment of Keratoacanthoma with 5% Imiquimod Cream and Review of the Previous Report

@inproceedings{Jeon2011TreatmentOK,
  title={Treatment of Keratoacanthoma with 5% Imiquimod Cream and Review of the Previous Report},
  author={Hye Chan Jeon and Mira Choi and Seung Hwan Paik and Chang Ho Ahn and Hyun Sun Park and Kwang Hyun Cho},
  booktitle={Annals of dermatology},
  year={2011}
}
Keratoacanthoma (KA) is a benign epidermal tumor, characterized by rapid and abundant growth, a tendency toward spontaneous regression and histopathologic similarity to squamous cell carcinoma (SCC). Because KA can be easily misdiagnosed as SCC, surgery is considered the treatment of choice. Recently, regression of KAs following application of 5% imiquimod cream (Aldara®) has been reported. We present 4 cases of KA treated with topical imiquimod, applied 3 to 4 times a week. Obvious improvement… CONTINUE READING